← Leaderboards
Zhi Hong Lu
Washington University
$531,665
Attributed
$531,665
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.3K · FY2005–24$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$531,665 · 2
By mechanism
R21$427,625 · 1
F32$104,040 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Julio Perez Fontan$6,092,819
- Ronald Drew Etheridge$4,599,261
- Jeffrey H Miner$20,654,870
- David R Piwnica-Worms$22,122,563
- James W Harbour$11,773,196
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionGenerationsFiberGene Delivery SystemBase EditingCapsidAdenovirusesBiomedical EngineeringCell TherapyAdverse EffectsChemistryChimeric Antigen Receptor T CellsClinical PracticeClustered Regularly Interspaced Short Palindromic RepeatsCar T Cell TherapyCoronary FibrosisCostCouplingDelivery VehicleDependovirusDesignCell TypeEngineeringGenes
Grant awards (4)
A Novel Vector Strategy to Feasibilize Cellular Therapy for Heart Disease$233,250
R21 · FY2024 · HL · contact PI
A Novel Vector Strategy to Feasibilize Cellular Therapy for Heart Disease$194,375
R21 · FY2023 · HL · contact PI
Correction of globin gene mutations by gene targeting$53,492
F32 · FY2005 · HL
Correction of globin gene mutations by gene targeting$50,548
F32 · FY2004 · HL